Clinical StrategyPublished: April 21, 2026
The Hidden Cost of a 30-Day IND Delay
B
Beacon Compliance Team
Biopharma Intelligence Unit
When a 30-day IND delay happens, it rarely shows up as a 30-day delay in the final program timeline. It shows up as 6–18 months of compounded delays by the time you reach Phase 3.